Search
Close this search box.

Category

Category

Minimum Deposit Casinos Announces Completion of Full Website Revamp

Before and After: MDC Website Redesign Comparison of the Minimum Deposit Casinos website before and after the comprehensive redesign. The updated site features streamlined navigation, enhanced functionality, a modern aesthetic, updated logo, and improved user-centric features. WATERFORD, Ireland, July 15, 2024 (GLOBE NEWSWIRE) — Minimum Deposit Casinos (MDC), a premier

BASF Environmental Catalyst and Metal Solutions inaugure un nouvel investissement dans l’hydrogène vert à Budenheim, en Allemagne

La nouvelle installation produira des composants pour l’électrolyse et les piles à combustible afin de soutenir la transition énergétique mondiale La production devrait commencer à l’été 2025 Investissement conjoint avec d’autres partenaires BUDENHEIM, Allemagne, 11 juill. 2024 (GLOBE NEWSWIRE) — BASF Environmental Catalyst and Metal Solutions (ECMS) a entamé la

BASF Environmental Catalyst and Metal Solutions inaugure un nouvel investissement dans l’hydrogène vert à Budenheim, en Allemagne

La nouvelle installation produira des composants pour l’électrolyse et les piles à combustible afin de soutenir la transition énergétique mondiale La production devrait commencer à l’été 2025 Investissement conjoint avec d’autres partenaires BUDENHEIM, Allemagne, 11 juill. 2024 (GLOBE NEWSWIRE) — BASF Environmental Catalyst and Metal Solutions (ECMS) a entamé la

Discover Innovation and Rewards at CHINT Limitless 2024 Super Brand Season

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June 1st to July 31st, 2024. This exciting campaign aims to honor electricians, installers, and panel builders worldwide, recognizing their invaluable

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment

About Us

Promoting revolutionary values and uniting movements for South Africa’s economic freedom.

Newsletter

Enter your email address below to subscribe to my newsletter